Dr. Wiesenfeld is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
701 10th St Se
Hpcc 3rd Floor
Cedar Rapids, IA 52403Phone+1 319-363-8303Fax+1 319-364-4659
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1978 - 1979
- University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1977 - 1978
- Hennepin HealthcareResidency, Internal Medicine, 1974 - 1977
- Hennepin HealthcareInternship, Transitional Year, 1973 - 1974
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1973
Certifications & Licensure
- IA State Medical License 1977 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
Clinical Trials
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2005 May 01
- Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2006 Mar 24
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
- Join now to see all
Publications & Presentations
PubMed
- 106 citationsPrognostic Value of Proliferation, Apoptosis, Defective DNA Mismatch Repair, and p53 Overexpression in Patients With Resected Dukes' B2 or C Colon Cancer: A North Cent...Megan M. Garrity, Lawrence J. Burgart, Michelle R. Mahoney, Harold E. Windschitl, Muhammad Salim
Journal of Clinical Oncology. 2016-09-21 - 6 citationsPhase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic b...Winston Tan, Jacob B. Allred, Muhammad Salim, Patrick J. Flynn, Paul A. S. Fishkin
Clinical Breast Cancer. 2012-04-01 - 28 citationsPhase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group resultsMarta Santisteban, Jan C. Buckner, Joel M. Reid, Wenting Wu, Bernd W. Scheithauer
Journal of Neuro-Oncology. 2009-01-01
Grant Support
- Cedar Rapids Oncology ProjectNational Cancer Institute1993–2009
- Cedars Rapids Oncology ProjectNational Cancer Institute1990–1992
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: